<DOC>
	<DOCNO>NCT00577473</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy Asacol 4.8 g/day ( 800 mg tablet ) versus Asacol 2.4 g/day ( 400 mg tablet</brief_summary>
	<brief_title>Safety Efficacy Asacol 4.8 g/Day Versus Asacol 2.4 g/Day ( ASCEND I )</brief_title>
	<detailed_description>This study design evaluate safety efficacy 4.8 g/day use 800 mg Asacol tablet compare 2.4g/day use 400 mg Asacol tablet newly- previously-diagnosed patient experience flare-up mildly moderately active ulcerative colitis .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>confirm diagnosis ulcerative colitis history allergy hypersensitivity salicylates aminosalicylates ; history extensive small bowel resection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>